Page last updated: 2024-08-25

rosiglitazone and Shock

rosiglitazone has been researched along with Shock in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Caputi, AP; Chatterjee, PK; Cuzzocrea, E; Cuzzocrea, S; Di Paola, R; Di Rosa, M; Dugo, L; Fulia, F; Genovese, T; Ianaro, A; Patel, NS; Pisano, B; Thiemermann, C1

Other Studies

1 other study(ies) available for rosiglitazone and Shock

ArticleYear
Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces the development of nonseptic shock induced by zymosan in mice.
    Critical care medicine, 2004, Volume: 32, Issue:2

    Topics: Animals; Lipid Peroxidation; Male; Mice; Multiple Organ Failure; Nitric Oxide; Nitrosation; Rosiglitazone; Shock; Thiazolidinediones; Zymosan

2004